Mirum Pharmaceuticals (MIRM) Other Operating Expenses (2021 - 2026)

Mirum Pharmaceuticals has reported Other Operating Expenses for 6 years, with the latest figure at $755.1 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses rose 2595.08% year-over-year to $755.1 million; the trailing twelve-month figure through Mar 2026 stood at $832.3 million (up 806.37% YoY), and the FY2025 full-year result was $100.2 million, up 22.78% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $755.1 million, up from $28.3 million in the prior quarter.
• The five-year high for Other Operating Expenses was $755.1 million in Q1 2026, with the low at $2.4 million in Q1 2022.
• Average Other Operating Expenses over 5 years is $58.9 million, with a median of $20.2 million recorded in 2024.
• Year-over-year, Other Operating Expenses decreased 8.95% in 2024 and soared 2595.08% in 2026.
• Tracing MIRM's Other Operating Expenses over 5 years: stood at $4.5 million in 2022, then soared by 456.74% to $25.0 million in 2023, then retreated by 8.95% to $22.8 million in 2024, then advanced by 24.07% to $28.3 million in 2025, then surged by 2571.62% to $755.1 million in 2026.
• The last three Other Operating Expenses figures came in at $755.1 million (Q1 2026), $28.3 million (Q4 2025), and $25.5 million (Q3 2025), per Business Quant data.

Peer Comparison